Sildenafil as a treatment for pulmonary hypertension

Archives of Disease in Childhood

Volumn 88, Issue 9, 2003, Pages 827-828

  Carroll, W D ^a   Dhillon, R ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN; HYDROXYCHLOROQUINE; METHOTREXATE; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL; STEROID; TUBERCULOSTATIC AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHILD; CHILDHOOD; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; MALE; MONOTHERAPY; OPEN LUNG BIOPSY; OXYGEN THERAPY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIHYPERTENSIVE AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; HYPERTENSION, PULMONARY; MALE; PIPERAZINES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0042261614     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.9.827     Document Type: Article

References (9)

1. Gibbs JSR. Recommendations on the management of pulmonary hypertension in clinical practice. Heart 2001;86(suppl 1):i1-i13.
2. Barst R J, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999;99:1197-208.
3. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The primary pulmonary hypertension group. N Engl J Med 1996;334:296-302.
4. Prasad S, Wilkinson J, Gatzoulis MA. Sildenafil in primary pulmonary hypertension. N Engl J Med 2000;343:1342.
5. Ghofrani HA, Wiedemann R, Rods F, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002;136:515-22.
6. Abrams D, Schulze-Neick I, Magee AG. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 2000;84:e4.
7. Zhao L, Mason NA, Morrell NW, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 2001;104:424-8.
8. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903.
9. Barst RJ, Rich S, Widlitz A, et al. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension. Chest 2002;121:1860-8.